S. Cooley

发表

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

L. Lanier, Jeffrey S. Miller, D. Weisdorf, 2012, Blood.

Allogeneic natural killer cells for refractory lymphoma

B. Lindgren, Jeffrey S. Miller, D. Weisdorf, 2010, Cancer Immunology, Immunotherapy.

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Peter Parham, Tracy L. Bergemann, Chap T. Le, 2009, Blood.

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.

P. Parham, K. van Besien, S. Farag, 2020, Blood advances.

Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.

P. Parham, Jeffrey S. Miller, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

KIR Donor Selection: Feasibility in Identifying better Donors.

P. Parham, S. Marsh, S. Spellman, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Running Title: Tim-3 function in human NK cells

T. Niki, M. Hirashima, Jeffrey S. Miller, 2016 .

Killer Cell Immunoglobulin-Like Receptors in Clinical Transplantation

R. Rajalingam, S. Cooley, J. Bergen, 2016 .

The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)

Jeffrey S. Miller, M. Verneris, B. Foley, 2014, Immunological reviews.

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.

T. Niki, M. Hirashima, Jeffrey S. Miller, 2012, Blood.

Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.

Jeffrey S. Miller, M. Verneris, J. Spanholtz, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical production and therapeutic applications of alloreactive natural killer cells.

Jeffrey S. Miller, D. Kadidlo, D. McKenna, 2012, Methods in molecular biology.

T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

J. Dipersio, D. Porter, S. Farag, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Natural killer cells and tumor control

S. Cooley, D. Weisdorf, 2010, Current opinion in hematology.

Clinical trials of NK cells for cancer

Jeffrey S. Miller, S. Cooley, 2010 .

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype.

J. Klein, Jeffrey S. Miller, S. Spellman, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, M. Verneris, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Jeffrey S. Miller, S. Spellman, D. Weisdorf, 2005, Blood.

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

J. Klein, P. Parham, M. Horowitz, 2007, Blood.

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006, Blood.

Infusion reactions in natural killer cell immunotherapy: a retrospective review.

T. Mamo, Jeffrey S. Miller, D. McKenna, 2021, Cytotherapy.

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

T. Waldmann, G. Vercellotti, Jeffrey S. Miller, 2019, Blood advances.

First in Human Phase I Trial of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Cancer

C. Yunis, Jeffrey S. Miller, A. Dudek, 2007, Clinical Cancer Research.

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

D. Kaufman, J. Wagner, K. Dusenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.

Jeffrey S. Miller, S. Spellman, D. Weisdorf, 2018, Blood advances.

Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802 Biol Blood Marrow Transplant .

Gabrielle, Meyers, G. Vercellotti, 2015 .

Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation.

D. Porter, Jeffrey S. Miller, E. Hexner, 2009, Cancer treatment and research.

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

Jeffrey S. Miller, D. Weisdorf, A. Panoskaltsis-Mortari, 2018, Cancer Immunology, Immunotherapy.

Adoptive Therapy with T Cells/NK Cells

C. June, Jeffrey S. Miller, S. Schoenberger, 2007 .

Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.

Bin Zhang, Jeffrey S. Miller, S. Spellman, 2016, Cancer research.

The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples.

Jeffrey S. Miller, D. Weisdorf, A. Rashidi, 2019, Blood advances.

Neurological Consequences of Cytokine Release Syndrome Following Subcutaneous Recombinant IL-15 and Haploidentical Donor Natural Killer Cell Therapy for Advanced Acute Myeloid Leukemia

T. Waldmann, G. Vercellotti, Jeffrey S. Miller, 2017 .

Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant

S. Furlan, Jeffrey S. Miller, B. Blazar, 2017, Science Translational Medicine.

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Paul C. Rogers, Bin Zhang, Jeffrey S. Miller, 2017, Cancer research.

An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia

G. Borthakur, D. Rizzieri, L. Brail, 2016, Leukemia & lymphoma.

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

J. Tolar, Bin Zhang, Jeffrey S. Miller, 2016, Clinical Cancer Research.

disintegrin and metalloprotease-17 (ADAM17) NK cell CD16 surface expression and function is regulated by a

B. Foley, S. Cooley, Xianghua Luo, 2013 .

Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.

J. Wagner, Jeffrey S. Miller, D. Vallera, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

decitabine vorinostat and haploidentical natural killer cell infusions with il 2 atimulation in high risk myelodysplastic syndrome

M. Patnaik, J. Miller, D. McKenna, 2018 .

A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.

P. Westervelt, J. Dipersio, L. Gorelik, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Bin Zhang, Jeffrey S. Miller, D. Weisdorf, 2014, Blood.

Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells.

Jeffrey S. Miller, J. Gotlib, D. Vallera, 2018, Blood advances.

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.

P. Parham, J. Wagner, Jeffrey S. Miller, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adaptive NK cell and KIR-expressing T cell responses are induced by CMV and are associated with protection against CMV reactivation after allogeneic donor hematopoietic cell transplantation Blood Marrow Transplant .

P. Parham, J. Wagner, D. Weisdorf, 2015 .

This information is current as Response to Recipient CMV Antigen Transplantable and Expand In Vivo in NK Cells Are + Memory-like NKG 2 C Human Cytomegalovirus ( CMV )-Induced Anasetti

Jeffrey S. Miller, D. Weisdorf, C. Anasetti, 2012 .

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

Jeffrey S. Miller, D. Weisdorf, M. Verneris, 2011, Blood.

recovery of cytokine-producing and cytotoxic functions NK cell education after allogeneic transplantation : dissociation between

Jeffrey S. Miller, D. Weisdorf, M. Verneris, 2011 .

"Self"-reflection by KIR.

Jeffrey S. Miller, S. Cooley, 2009, Blood.

Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.

S. Furlan, Jeffrey S. Miller, B. Blazar, 2016, Blood.

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression

S. Anderson, Jeffrey S. Miller, Hongchuan Li, 2014, Genes and Immunity.

Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.

Jeffrey S. Miller, M. Verneris, V. Bachanova, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

J. Klein, P. Parham, Jeffrey S. Miller, 2007 .

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL.

Jeffrey S. Miller, D. Weisdorf, V. Bachanova, 2019, Blood advances.

A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.

J. Wagner, Xiyan Xu, Jeffrey S. Miller, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.

K. Hsu, Jeffrey S. Miller, J. Fischer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Angioimmunoblastic T-cell lymphoma of the oral cavity presenting as gingival mass: report of the histopathologic and molecular characteristics of an unusual case featuring clonal T-cell receptor γ gene rearrangement by polymerase chain reaction.

I. Koutlas, S. Yohe, S. Cooley, 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2017, Bone Marrow Transplantation.

Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control

Jeffrey S. Miller, V. Bachanova, D. McKenna, 2019, Journal of immunotherapy.

Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

G. Vercellotti, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2018, Blood advances.

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

P. Parham, Jeffrey S. Miller, T. Bergemann, 2007, Blood.

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

J. Wagner, P. Westervelt, J. Dipersio, 2018, Blood.

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.

F. Gao, P. Westervelt, J. Dipersio, 2021, Blood.

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control

C. Kalberer, E. Alici, M. Lowdell, 2015, Oncoimmunology.

Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.

P. Parham, Jeffrey S. Miller, S. Cooley, 2018, Blood.

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

H. Ljunggren, T. Clancy, E. Hellström-Lindberg, 2018, Clinical Cancer Research.

Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells.

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

P. Parham, Jeffrey S. Miller, S. Marsh, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT

J. Wagner, Bin Zhang, Jeffrey S. Miller, 2015, Leukemia.

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.

L. Downs, K. Dusenbery, P. Judson, 2011, Cytotherapy.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Chap T Le, Tao Wang, John P Klein, 2010, Blood.

Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers

L. Downs, P. Judson, Jeffrey S. Miller, 2010, Cancer Immunology, Immunotherapy.

Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention

C. Ziegler, S. Furlan, D. Promislow, 2015, Science Translational Medicine.

survival after unrelated transplantation for acute myelogenous leukemia Donor selection for natural killer cell receptor genes leads to superior

J. Klein, C. Le, P. Parham, 2010 .

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2008, Blood.

Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

J. Klein, P. Parham, Jeffrey S. Miller, 2014, The Journal of Immunology.

NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17).

Bin Zhang, Jeffrey S. Miller, B. Foley, 2013, Blood.

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

Jeffrey S. Miller, J. Miller, T. Repka, 1999, Experimental hematology.

Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen

Jeffrey S. Miller, D. Weisdorf, C. Anasetti, 2012, The Journal of Immunology.

Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma.

Jeffrey S. Miller, D. Weisdorf, V. Bachanova, 2021, Transplantation and cellular therapy.

Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Jeffrey S. Miller, M. Verneris, J. Curtsinger, 2016, Blood advances.

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

C. Le, K. Dusenbery, Jeffrey S. Miller, 2006 .

Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string

S G E Marsh, M Maiers, J A Hollenbach, 2013, Tissue antigens.

Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01

Wesley M. Marin, P. Parham, Jeffrey S. Miller, 2021, The Journal of Immunology.

Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis

P. Parham, Stephanie J. Lee, S. Spellman, 2019 .

Myelogenous Leukemia Unrelated Transplantation for Acute Mismatch Enhance the Clinical Benefit of Haplotypes, Recipient HLA-C1, and HLA-C Donor Killer Cell Ig-like Receptor B

Martha, Jeffrey, J. Klein, 2014 .

NK cell CD 16 surface expression and function is regulated by a disintegrin and metalloprotease-17 ( ADAM 17 )

Bin Zhang, Jeffrey S. Miller, B. Foley, 2013 .

The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2016, Current topics in microbiology and immunology.

cells is improved using IL-2 diphtheria toxin fusion protein Clearance of acute myeloid leukemia by haploidentical natural killer

Bin Zhang, D. Weisdorf, B. Blazar, 2014 .

APOLLO: A phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer.

M. Wallet, Jeffrey S. Miller, D. Teoh, 2020 .

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

M. Linden, A. Rashidi, J. Miller, 2018, Bone Marrow Transplantation.

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2016 .

Interim Phase I Clinical Data of FT819-101, a Study of the First-Ever, Off-the-Shelf, iPSC-Derived TCR-Less CD19 CAR T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies

R. Elstrom, L. Wong, U. Farooq, 2022, Blood.

Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation

P. Parham, Jeffrey S. Miller, P. Norman, 2015, The Journal of Immunology.

Prolonged subcutaneous administration of 852A, a novel systemic toll‐like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2012, American journal of hematology.

Adaptive NK cell reconstitution is associated with better clinical outcomes.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2019, JCI insight.

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML

E. Tholouli, N. Russell, J. Byrne, 2020, Bone Marrow Transplantation.

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

J. Karn, J. Safrit, D. Douek, 2022, Nature Medicine.

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

J. Klein, P. Parham, M. Horowitz, 2006 .

Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.

T. DeFor, N. Majhail, S. Cooley, 2013, Blood.

measured liver iron content − transplantation outcomes : a prospective cohort study using R 2-MRI Association of iron overload with allogeneic hematopoietic cell

T. DeFor, N. Majhail, S. Cooley, 2013 .

Allogeneic hematopoietic cell transplantation in morphologic leukemia‐free aplastic state

P. Westervelt, J. Dipersio, Kiran R. Vij, 2017, American journal of hematology.

Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37

Bin Zhang, Jeffrey S. Miller, B. Blazar, 2018, Cancer Immunology Research.

Robust Feature Selection Technique Using Rank Aggregation

Jaideep Srivastava, Chandrima Sarkar, Sarah Cooley, 2014, Appl. Artif. Intell..

A phase II randomized, double-blind study of sipuleucel-T followed by IDO pathway inhibitor, indoximod, or placebo in the treatment of patients with metastatic castration resistant prostate cancer (mCRPC).

J. Koopmeiners, Jeffrey S. Miller, S. Tagawa, 2017 .

A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors.

Shohreh H Sikaroodi, K. Wucherpfennig, Tianhao Xu, 2023, Med.

A phase I study of lirilumab (BMS-986015), an anti-KIR monoclonal antibody, administered in combination with ipilimumab, an anti-CTLA4 monoclonal antibody, in patients (Pts) with select advanced solid tumors.

F. Hodi, G. Gibney, N. Rizvi, 2013 .

Safety of the natural killer (NK) cell-targeted anti-KIR antibody, lirilumab (liri), in combination with nivolumab (nivo) or ipilimumab (ipi) in two phase 1 studies in advanced refractory solid tumors

J. Wolchok, F. Hodi, G. Gibney, 2016 .

Recombinant Human IL-15 Promotes in Vivo Expansion of Adoptively Transferred NK Cells in a First-in-Human Phase I Dose Escalation Study in Patients with AML

T. Waldmann, Jeffrey S. Miller, D. Weisdorf, 2012 .

204 Combining FT536, a pan-tumor targeting CAR NK cell therapy, with CD16 engagers provides a coordinated targeting strategy to overcome tumor heterogeneity

Shohreh H Sikaroodi, Bryan M. Hancock, J. Powderly, 2022, Regular and Young Investigator Award Abstracts.

Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products

D. McKenna, R. Skeate, S. Cooley, 2013, Transfusion.

Haploidentical Natural Killer (NK) Cells Expanding In Vivo After Adoptive Transfer Exhibit Hyperfunction That Partially Overcomes Self Tolerance and Leads to Clearance of Refractory Leukemia

K. Dusenbery, Jeffrey S. Miller, D. Weisdorf, 2011 .

A Phase I Study of FT538, an Off-the-Shelf, Multiplexed-Engineered, iPSC-Derived NK Cell Therapy in Combination with Daratumumab in Relapsed/Refractory Multiple Myeloma

R. Vij, L. Wong, Bahram Valamehr, 2022, Blood.

Initial Clinical Activity of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma

Jeffrey S. Miller, V. Bachanova, Z. Cayci, 2020 .

Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma

L. Wong, Bahram Valamehr, Xingyue Zong, 2022, Blood.

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

J. Tolar, Jeffrey S. Miller, S. Spellman, 2016 .

Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion

J. Tolar, Bin Zhang, Jeffrey S. Miller, 2015 .

Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia

Jeffrey S. Miller, J. Gotlib, D. Weisdorf, 2017, American journal of hematology.

First-in-Human Phase I Study of Nicotinamide-Expanded Related Donor Natural Killer Cells for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Jeffrey S. Miller, D. Weisdorf, V. Bachanova, 2019, Biology of Blood and Marrow Transplantation.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Bin Zhang, Jeffrey S. Miller, D. Weisdorf, 2014, Blood.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

C. Le, P. Parham, Jeffrey S. Miller, 2010, Blood.

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2008 .

cells is improved using IL-2 diphtheria toxin fusion protein Clearance of acute myeloid leukemia by haploidentical natural killer

Bin Zhang, D. Weisdorf, B. Blazar, 2014 .

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

Jeffrey S. Miller, D. Weisdorf, M. Verneris, 2011, Blood.

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, M. Verneris, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Paul C. Rogers, Bin Zhang, Jeffrey S. Miller, 2017, Cancer research.

CD38-Deficient, CD16-Engineered NK Cells Exhibit Enhanced Antibody-Dependent Cellular Cytotoxicity without NK Cell Fratricide to Augment Anti-Myeloma Immunity in Combination with Daratumumab

D. Kaufman, Jeffrey S. Miller, Bahram Valamehr, 2018, Blood.

Second-Generation Camelid Trike Induces Improved NK Cell Mediated Targeting of AML in Pre-Clinical Models

Jeffrey S. Miller, D. Weisdorf, M. Geller, 2017 .

Improved feature selection for hematopoietic cell transplantation outcome prediction using rank aggregation

Jaideep Srivastava, Chandrima Sarkar, Sarah Cooley, 2012, 2012 Federated Conference on Computer Science and Information Systems (FedCSIS).

A Phase I Study of Intravenous NCI IL-15 to Enhance Adoptively Transferred NK Cells Uncovers Defects in CD16 Triggered IFNγ Production and Competition Between Donor NK and Recipient T Cells

T. Waldmann, Jeffrey S. Miller, D. Weisdorf, 2015 .

Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention

S. Furlan, D. Promislow, Jeffrey S. Miller, 2015, Science Translational Medicine.